Synapse - Find an Expert

4640 Results

Genetic algorithms to identify homologous recombination deficiency (HRD) in pancreas adenocarcinoma

Meeting Abstract

Park, W.; Chen, J.; Chou, J. F.; Iacobuzio-Donague, C.; Riaz, N.; O'Reilly, E. M.
Cancer Research (2020)

Fulltext@MSK | Save

Pancreatic cancer prognosis is predicted by chromatin accessibility microarray

Meeting Abstract

Dhara, S.; Chhangawala, S.; Chintalapudi, H.; Massa, A. L.; Aveson, V.; Askan, G.; Zhang, L.; Nicolle, R.; Makohon-Moore, A. P.; Sinha, S.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Cell state diversity promotes metastasis through heterotypic cluster formation in melanoma

Meeting Abstract

Campbell, N. R.; Zhang, M.; Baron, M.; Heilmann, S.; Deforet, M.; Ferretti, L.; Huang, T. H.; Levesque, M. P.; Yanai, I.; Xavier, J. B.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Oncologic therapy shapes the fitness landscape of clonal hematopoiesis

Meeting Abstract

Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
Cancer Research (2020)

Fulltext@MSK | Save

OncoMatch: Unbiased, quantitative assessment of cancer model fidelity for drug sensitivity and mechanism of action elucidation

Meeting Abstract

Alvarez, M. J.; Pengrong, Y.; Alpaugh, M. L.; Bowden, M.; Sicinska, E. T.; Zhou, C. W.; Karan, C.; Realubit, R. B.; Mundi, P. S.; Grunn, A.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors

Meeting Abstract

Messersmith, W.; Rasco, D.; De Bono, J.; Wang-Gillam, A.; Park, W.; Nickle, D.; Galkin, A.; Ferguson, B.; Carter, L.; Zhou, L.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

CDX1140-01, a phase 1 dose-escalation/expansion study of CDX-1140 alone (part 1) and in combination with CDX-301 (part 2) or pembrolizumab (part 3)

Meeting Abstract

Sanborn, R.; Hauke, R.; Gabrail, N.; O'Hara, M.; Bhardwaj, N.; Bordoni, R.; Gordon, M.; Khalil, D.; Abdelrahim, M.; Marron, T.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Preliminary results from Keynote-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors

Meeting Abstract

Bendell, J.; Messersmith, W.; Rasco, D.; Wang-Gillam, A.; Park, W.; Zhou, L.; Carter, L.; Bruey, J. M.; Li, J.; Ferguson, B.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Phase IB/II open-label, randomized evaluation of atezolizumab (atezo) plus selicrelumab (seli) plus gemcitabine plus nab-paclitaxel (gem plus nabP) or bevacizumab (bev) vs control in MORPHEUS-PDAC, -TNBC and -CRC